Skip to Content


In the US, Valganciclovir (valganciclovir systemic) is a member of the drug class purine nucleosides and is used to treat CMV Prophylaxis and CMV Retinitis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiviral agent

Nucleoside analogue

Chemical Names

(RS)-2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)metoxy]-3-hydroxypropyl (S)-2-amino-3-metylbutanoat (IUPAC)

L-Valine, ester wit 9-[[2-hydroxy-1-(hydroxymetyl)-etoxy]metyl]guanine (WHO)

Foreign Names

  • Valganciclovirum (Latin)
  • Valganciclovir (German)
  • Valganciclovir (French)
  • Valganciclovir (Spanish)

Generic Names

  • Valganciclovir (OS: BAN)
  • Valine ester prodrug of ganciclovir (IS)
  • Valganciclovir Hydrochloride (OS: BANM, USAN, JAN)
  • Cymeval (IS)
  • Ganciclovir valine hydrochloride (IS)
  • Ro 1079070/194 (IS: HoffmannLaRoc)
  • RS 079070-194 (IS: HoffmannLaRoc)
  • Valcyt (IS)
  • Valganciclovir Hydrochloride (PH: USP 38)

Brand Names

  • Alvanocyt
    Alvogen, Croatia (Hrvatska); Alvogen, Netherlands
  • Ceglar
    Sandoz, Poland
  • Ganaxa
    Teva, Slovenia
  • Nyctos
    Sandoz, Croatia (Hrvatska)
  • Rovalcyte
    Roche, Portugal
  • Valcyclox
    STADA, Poland
  • Valcyte
    Al Masria, Egypt; Patheon, Georgia; Roche, Israel; Roche, Lebanon; Roche, Poland; Roche, Turkey
  • Valdamin
    Egis Pharmaceuticals, Poland
  • Valgan
    Cipla, India
  • Valganciclovir Aurobindo
    Aurobindo, Malta
  • Valganciclovir Teva
    Teva Pharmaceuticals, Poland
  • Valganciklovir Aurobindo
    Aurobindo Pharma, Croatia (Hrvatska)
  • Valganciklovir Lek
    Lek, Slovenia
  • Valganciklovir Pliva
    Pliva, Croatia (Hrvatska)
  • Apo-Valganciclovir
    Apotex, Georgia
  • Darilin
    Recordati, Italy
  • Rovalcyte
    Roche, France
  • Valcyte
    Dr. F. Hoffmann-Lja - Roche, Russian Federation; Eureco-Pharma, Netherlands; Euro Registratie, Netherlands; Fisher Farma, Netherlands; Haemato Pharm, Austria; Hoffmann-La Roche Ltd, Latvia; Orifarm, Netherlands; Roche, Armenia; Roche, Australia; Roche, Belgium; Roche, Bulgaria; Roche, Canada; Roche, China; Roche, Czech Republic; Roche, Germany; Roche, Denmark; Roche, Estonia; Roche, Spain; Roche, Finland; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Indonesia; Roche, Ireland; Roche, Iceland; Roche, Italy; Roche, Lithuania; Roche, Moldova; Roche, Malta; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Oman; Roche, Philippines; Roche, Romania; Roche, Serbia; Roche, Sweden; Roche, Slovenia; Roche, Thailand; Roche, United States; Roche, South Africa; Roche Austria, Austria; Roche Products, United Kingdom
  • Valdamin
    Egis, Netherlands
  • Valganciclovir Aurobindo
    Aurobindo, Estonia; Aurobindo, Netherlands
  • Valganciclovir CF
    Centrafarm, Netherlands
  • Valganciclovir Fisher
    Fisher Farma, Netherlands
  • Valganciclovir Mylan
    Mylan, Netherlands
  • Valganciclovir Sandoz
    Sandoz, Switzerland; Sandoz, Estonia; Sandoz, Netherlands
  • Valganciclovir Teva
    Teva, Spain; Teva, Netherlands
  • Valganciclovir Zentiva
    Helvepharm, Switzerland
  • Valganciclovir-Mepha
    Mepha Pharma, Switzerland
  • Valixa
    Productos Roche, Chile; Roche, Argentina; Roche, Colombia; Roche, Ecuador; Roche, Uruguay; Tanabe Mitsubishi Pharma, Japan


BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.